GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is currently emerging as a major focus in healthcare studies, largely due to its notable impact on managing ailments such as type 2 diabetes and excess body fat. Ongoing research have shown that more than glucose management, GLP-1 medications offer benefits for heart well-being and perhaps